In essence, NAT10 remodels the tumor metabolic landscape by increasing the flux through glycolytic and biosynthetic pathways, thereby fueling the anabolic demands of rapid proliferation (Fig. 2, Table 1). The gene discussed is NAT10; the disease is neoplasm.